Treatment of Angioedema Attacks in Adolescent and Adult Patients 12 Years and Older With HAE Type I or II With Sebetralstat

Inclusion Criteria: * At least 12 years of age. * Able to provide written, informed consent or assent. * Confirmed diagnosis of HAE Type I or II. Exclusion Criteria: * Confirmed diagnosis of HAE with nC1-INH or acquired angioedema. * Confirmed pregnancy or breast-feeding. * Any clinically significant medical condition or medical history that, in the opinion of the Treating Physician, would interfere with the patient's safety. * Known hypersensitivity to sebetralstat or its excipients. * Patient with a medical history or known to have severe hepatic impairment (Child Pugh C). * Patients who require sustained use of strong cytochrome P450 3A4 inhibitors or inducers.